Veronica Byfield Sköld
Director Ejecutivo en BioLamina AB .
Perfil
Veronica Byfield Sköld is currently the Chief Executive Officer at BioLamina AB.
Previously, she worked as the Chief Sales Officer at Clemondo Group AB.
She holds a graduate degree from the Royal Institute of Technology and an undergraduate degree from IHM Business School AB.
Cargos activos de Veronica Byfield Sköld
Empresas | Cargo | Inicio |
---|---|---|
BioLamina AB
BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | Director Ejecutivo | 01/10/2021 |
Antiguos cargos conocidos de Veronica Byfield Sköld.
Empresas | Cargo | Fin |
---|---|---|
CLEMONDO GROUP AB | Ventas & Marketing | - |
Formación de Veronica Byfield Sköld.
Royal Institute of Technology | Graduate Degree |
IHM Business School AB | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
CLEMONDO GROUP AB | Consumer Non-Durables |
Empresas privadas | 1 |
---|---|
BioLamina AB
BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | Health Technology |
- Bolsa de valores
- Insiders
- Veronica Byfield Sköld